Blume Equity, an emerging manager with a “healthy planet, healthy people” mantra, has inked its first investment – an investment in femtech company Elvie – as it starts to raise capital for its first fund. It is targeting €200 million, according to a source with knowledge of the firm, to make growth investments in the food- and healthcare-related companies. Blume declined to comment on the fundraise.
The firm participated in a Series C funding round for Elvie, a producer of tech-enabled breast pumps and pelvic floor training devices. You can read more about the deal on TechCunch here.
Blume is led by trio of female co-founders:
- Michelle Capiod is a former investment banker who then spent 13 years at private equity firm Mid Europa Partners, latterly as partner.
- Clare Murray is a veteran of impact investing GP Leapfrog and BlackRock, where she helped establish its sustainable investment platform.
- Eleanor Blagbrough spent more than a decade at UK mid-market firm ECI Partners, having previously been at consultant McKinsey & Co.